ClinVar Miner

Submissions for variant NM_001378609.3(OTOGL):c.841_842del (p.Met281fs)

dbSNP: rs876657658
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000220106 SCV000271255 likely pathogenic Rare genetic deafness 2015-06-11 criteria provided, single submitter clinical testing The p.Met272ValfsX4 variant in OTOGL has not been previously reported in individ uals with hearing loss, but has been identified in 2/12820 chromosomes by the Ex ome Aggregation Consortium (ExAC, http://exac.broadinstitute.org). Although this variant has been seen in the general population, its frequency is low enough to be consistent with a recessive carrier frequency. This variant is predicted to cause a frameshift, which alters the protein?s amino acid sequence beginning at position 272 and leads to a premature termination codon 4 amino acids downstream . This alteration is then predicted to lead to a truncated or absent protein. I n summary, although additional studies are required to fully establish its clini cal significance, this variant is likely pathogenic.
Labcorp Genetics (formerly Invitae), Labcorp RCV001383852 SCV001583162 pathogenic not provided 2024-02-28 criteria provided, single submitter clinical testing This sequence change creates a premature translational stop signal (p.Met272Valfs*4) in the OTOGL gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in OTOGL are known to be pathogenic (PMID: 23122586). This variant is present in population databases (rs776663993, gnomAD 0.005%). This variant has not been reported in the literature in individuals affected with OTOGL-related conditions. ClinVar contains an entry for this variant (Variation ID: 228285). For these reasons, this variant has been classified as Pathogenic.
Fulgent Genetics, Fulgent Genetics RCV001786342 SCV005630302 pathogenic Autosomal recessive nonsyndromic hearing loss 84B 2024-01-17 criteria provided, single submitter clinical testing
Service de Biologie Medicale, CIUSSS du Saguenay-Lac-Saint-Jean RCV001786342 SCV001712144 likely pathogenic Autosomal recessive nonsyndromic hearing loss 84B 2017-03-29 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.